NCT00116376 - Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Glioblastoma Multiforme

Interventions

DRUG

AEE788

Trial Locations (4)

The Brain Tumor Center at Duke, Duke University Medical Center, Box 3624 Dumc, Trent Drive, Durham

University of Texas, MD Anderson Cancer Center, Houston

University of California at Los Angeles, Los Angeles

University of California, San Francisco, San Francisco